This inventor holds 7 USPTO granted patents and 6 published patent applications and 7 EPO patents. Top assignees: Santen Sas, Novagali Pharma Sa. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Verrieres le Buisson, FR (2012 - 2017)
- Verrières le Buisson, FR (2015 - 2022)
Company Filing History:
Years Active: 2012-2022
Title: The Innovative Journey of Jean-Sébastien Garrigue
Introduction
Jean-Sébastien Garrigue, a distinguished inventor based in Verrières le Buisson, France, has significantly contributed to the field of pharmaceuticals with a strong focus on ocular treatments. With seven patents to his name, Garrigue has established himself as a pioneer in developing advanced solutions to address various ocular conditions.
Latest Patents
Garrigue's latest patents showcase his innovative approach to ocular healthcare. One notable patent is for "Polysaccharides for the Treatment of Ocular Conditions," which explores the use of a polysaccharide derived from a bacterial strain. This invention aims to prevent and treat ocular diseases, particularly addressing issues related to ophthalmic dryness and inflammation through the use of a specific polysaccharide obtained from the CNCM I-5038 bacterial strain.
Another significant innovation is the "Self-Preserved Oil Dispersions Comprising Boric Acid." This invention involves a self-preserved oil dispersion that consists of a dispersed oil phase, an aqueous phase, and at least one surfactant. With boric acid constituting 0.005% to 0.075% of the total weight, the oil dispersion provides effective preservative activity, thereby enhancing its stability and usability.
Career Highlights
Throughout his career, Jean-Sébastien Garrigue has made impactful contributions while working with leading companies in the industry. He has been associated with Santen Sas and Novagali Pharma SA, where his expertise in ocular pharmacology has been pivotal in driving innovative projects forward.
Collaborations
Collaboration has been a key aspect of Garrigue's success. He has worked alongside prominent colleagues in the field, including Betty Philips and Frédéric Lallemand, sharing insights and collaborating on groundbreaking research that advances ocular treatment methodologies.
Conclusion
Jean-Sébastien Garrigue's innovative work continues to shape the future of ocular healthcare. With seven active patents to his credit and ongoing collaborations with industry leaders, Garrigue exemplifies the spirit of innovation that drives the pharmaceutical industry forward, ensuring better health outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile